| Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS–cognitive and affective study CE Gleason, NM Dowling, W Wharton, JAE Manson, VM Miller, ... PLoS medicine 12 (6), e1001833, 2015 | 472 | 2015 |
| Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment SC Johnson, TW Schmitz, CH Moritz, ME Meyerand, HA Rowley, ... Neurobiology of aging 27 (11), 1604-1612, 2006 | 286 | 2006 |
| Recruitment and retention of underrepresented populations in Alzheimer's disease research: a systematic review AL Gilmore-Bykovskyi, Y Jin, C Gleason, S Flowers-Benton, LM Block, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 …, 2019 | 191 | 2019 |
| Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review ML Ries, CM Carlsson, HA Rowley, MA Sager, CE Gleason, S Asthana, ... Journal of the American Geriatrics Society 56 (5), 920-934, 2008 | 177 | 2008 |
| Increased risk for falling associated with subtle cognitive impairment: secondary analysis of a randomized clinical trial CE Gleason, RE Gangnon, BL Fischer, JE Mahoney Dementia and geriatric cognitive disorders 27 (6), 557-563, 2009 | 173 | 2009 |
| Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials E Liu, ME Schmidt, R Margolin, R Sperling, R Koeppe, NS Mason, ... Neurology 85 (8), 692-700, 2015 | 164 | 2015 |
| Neurobiological underpinnings of the estrogen-mood relationship W Wharton, C E Gleason, O Sandra, C M Carlsson, S Asthana Current psychiatry reviews 8 (3), 247-256, 2012 | 164 | 2012 |
| Anosognosia in mild cognitive impairment: relationship to activation of cortical midline structures involved in self-appraisal ML Ries, BM Jabbar, TW Schmitz, MA Trivedi, CE Gleason, CM Carlsson, ... Journal of the International Neuropsychological Society 13 (3), 450-461, 2007 | 146 | 2007 |
| Estrogen and Alzheimer’s disease: the story so far B Cholerton, CE Gleason, LD Baker, S Asthana Drugs & aging 19, 405-427, 2002 | 140 | 2002 |
| The Kronos early estrogen prevention study (KEEPS): what have we learned? VM Miller, F Naftolin, S Asthana, DM Black, EA Brinton, MJ Budoff, ... Menopause 26 (9), 1071-1084, 2019 | 130 | 2019 |
| Early postmenopausal transdermal 17β-estradiol therapy and amyloid-β deposition K Kantarci, VJ Lowe, TG Lesnick, N Tosakulwong, KR Bailey, JA Fields, ... Journal of Alzheimer's Disease 53 (2), 547-556, 2016 | 120 | 2016 |
| Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease CM Carlsson, CE Gleason, TM Hess, KA Moreland, HM Blazel, RL Koscik, ... Journal of Alzheimer's Disease 13 (2), 187-197, 2008 | 119 | 2008 |
| Oral contraceptives and androgenicity: influences on visuospatial task performance in younger individuals. W Wharton, E Hirshman, P Merritt, L Doyle, S Paris, C Gleason Experimental and clinical psychopharmacology 16 (2), 156, 2008 | 117 | 2008 |
| Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial W Wharton, LD Baker, CE Gleason, M Dowling, JH Barnet, S Johnson, ... Journal of Alzheimer's disease 26 (3), 495-505, 2011 | 111 | 2011 |
| Midlife predictors of Alzheimer's disease BB Bendlin, CM Carlsson, CE Gleason, SC Johnson, A Sodhi, ... Maturitas 65 (2), 131-137, 2010 | 109 | 2010 |
| A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women CE Gleason, CM Carlsson, JH Barnet, SA Meade, KDR Setchell, ... Age and ageing 38 (1), 86-93, 2009 | 105 | 2009 |
| Cerebrospinal fluid markers of Alzheimer’s disease pathology and microglial activation are associated with altered white matter microstructure in asymptomatic adults at risk … KE Melah, SYF Lu, SM Hoscheidt, AL Alexander, N Adluru, DJ Destiche, ... Journal of Alzheimer's Disease 50 (3), 873-886, 2016 | 101 | 2016 |
| Effect of cognitive reserve on age-related changes in cerebrospinal fluid biomarkers of Alzheimer disease RP Almeida, SA Schultz, BP Austin, EA Boots, NM Dowling, CE Gleason, ... JAMA neurology 72 (6), 699-706, 2015 | 98 | 2015 |
| Cognitive effects of soy isoflavones in patients with Alzheimer’s disease CE Gleason, BL Fischer, NM Dowling, KDR Setchell, CS Atwood, ... Journal of Alzheimer's Disease 47 (4), 1009-1019, 2015 | 98 | 2015 |
| Insulin resistance is associated with higher cerebrospinal fluid tau levels in asymptomatic APOE ɛ4 carriers EJ Starks, J Patrick O’Grady, SM Hoscheidt, AM Racine, CM Carlsson, ... Journal of Alzheimer's Disease 46 (2), 525-533, 2015 | 77 | 2015 |
